Latest News and Press Releases
Want to stay updated on the latest news?
-
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors,...
-
The race to develop more effective treatments for some of the deadliest forms of cancer is quietly unfolding across biotechnology
-
Eli Lilly's (NYSE:LLY) strong Phase 3 results for Retevmo places the oncology community in the spotlight
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Pfizer Inc. (PFE) (“Pfizer” or...